Back to search
FDAFDA · Food and drugs·Recall number D-0759-2026

SILDENAFIL CITRATE USP, 0.100 KG, 100 gm-bag Net Wt, RX ONLY "FOR Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesana, Gujarat, 382715, India, (CAS NO. 171599-83-0) NDC 85702-001-05

Published August 19, 2026 · Recall initiated: August 3, 2026

Summary

FDA records drug Class II recall D-0759-2026, published August 19, 2026 and initiated August 3, 2026. Recalling firm: Shoolin Pharma Chem LLP; Status: Ongoing; Reported quantity: 25KG, 250-1gm bags; Lot: Batch SDC2505001, Date of Expiry: April 30, 2030. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations:Noted during FDA inspection

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Shoolin Pharma Chem LLP
Distributor
Distributed Nationwide in the USA
Lot
Batch SDC2505001, Date of Expiry: April 30, 2030.
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was SILDENAFIL CITRATE USP, 0.100 KG, 100 gm-bag Net Wt, RX ONLY "FOR Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesana, Gujarat, 382715, India, (CAS NO. 171599-83-0) NDC 85702-001-05 recalled?

Yes. FDA published recall D-0759-2026 on August 19, 2026. Reported hazard: CGMP Deviations:Noted during FDA inspection

What should I do if I have this product?

Voluntary: Firm initiated